赛托生物：子公司收到化学原料药欧洲CEP证书

Core Viewpoint - Saito Bio's subsidiary, Shandong Sry Pharmaceutical Co., Ltd., has received the CEP certificate for Dexamethasone Sodium Phosphate from the European Directorate for the Quality of Medicines (EDQM), enhancing its position in the pharmaceutical market [1] Company Summary - Saito Bio's subsidiary, Shandong Sry Pharmaceutical, applied for the CEP certificate for Dexamethasone Sodium Phosphate in April 2024 and received it in October 2025 [1] - The drug Dexamethasone Sodium Phosphate is a corticosteroid with anti-inflammatory, anti-allergic, anti-rheumatic, and immunosuppressive properties, primarily used for allergic and autoimmune inflammatory diseases [1] Industry Summary - There are a total of 9 companies globally that hold valid CEP certificates for Dexamethasone Sodium Phosphate, including Shandong Sry Pharmaceutical [1]